Inclisirán as an alternative treatment for Hypercholesterolemia

Autor: Jorge Andrés Ojeda Villota, Javier Alfredo Pérez Martínez, Luis Alberto Burgos de Moya, Rodrigo Alfonso Chavez Vega, Roxana Rivera Valencia, Laura Melissa Medina Medina, María Paula González Rodríguez, Ingrith Tatiana Poveda Castillo

Publikováno v: World Journal of Advanced Research and Reviews. 12:517-521

Hypercholesterolemia (CH) is defined as the elevation of serum cholesterol levels, especially low-density lipoprotein (LDL) cholesterol, which is considered to be one of the most relevant risk factors for triggering cardiovascular disease, for This i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecb8e47708dd6b56edbb9ffc6e2d109
https://doi.org/10.30574/wjarr.2021.12.3.0694

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Letter to the editor - 'Olezarsen, a liver-directed APOC3 ASO therapy for hypertriglyceridemia'.

Autor: Leow MKS; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore, Singapore.; Department of Endocrinology, Division of Medicine, Tan Tock Seng Hospital, Singapore, Singapore.

Publikováno v: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2025 Jan; Vol. 26 (1), pp. 113. Date of Electronic Publication: 2024 Nov 21.